Search Results 761-770 of 17018 for pharmacogenetics

  1. Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. A Study to Evaluate the Feasibility of a Whole Blood Transfusion Program - Mayo Clinic

    About this study. The objective of the study is to identify a population of healthy blood donors that would be willing to donate blood within short notice ...

  3. Gastroenterology and Hepatology - Clinical trials

    The objective of this study is to compare the central neural circuitry with fMRI (7T) in 30 asymptomatic healthy controls, 30 constipated patients without ...

  4. A Study of Leukemia Inhibitory Factor Biomarker Monitoring Progression and Treatment Response of Locally-advanced Unresectable and Metastatic Pancreatic Cancer Therapies - Mayo Clinic

    The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...

  5. Focus areas - Liquid Biopsy and Translational Immunogenomics: Aadel A. Chaudhuri - Mayo Clinic Research

    The Chaudhuri Liquid Biopsy and Immunogenomics Lab at Mayo Clinic is focused on cancer risk and detection, immunotherapy, MRD detection, and precision ...

  6. A Study to Evaluate the Development of Patient Derived Xenografts in Patients With Breast Cancer - Mayo Clinic

    About this study. Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer.

  7. Publications - Zeying Du, M.D., Ph.D. - Mayo Clinic

    Du Z, Murrin ME, Kendrick JR, Williams CD, Elrefaei M. A Nine-Nucleotide Insertion Causes the Novel HLA-C*06:402 Allele in a Family Detected by ...

  8. Endocrinology - Clinical trials

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  9. Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Publications - Shant Ayanian, M.D. - Mayo Clinic

    Chambers S, Boyapati RB, Gagliasso R, Griebenow L, Ayanian S, Kohler C, Pagali S. Improving Hospital Delirium Screening and Documentation. Am J Nurs.